Insulin pump therapy for diabetes mellitus: nothing new, though familiar
| Autor: | Y. I. Filippov, A. Y. Mayorov |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2013 |
| Předmět: | |
| Zdroj: | Медицинский совет, Vol 0, Iss 6, Pp 92-98 (2013) |
| Druh dokumentu: | article |
| ISSN: | 2079-701X 2658-5790 |
| DOI: | 10.21518/2079-701X-2013-6-92-98 |
| Popis: | Diabetes mellitus (DM) is one of the most common chronic diseases worldwide. According to the International Diabetes Federation (IDF), the number of adult patients (20-79 years) will reach 552 million people by 2030 globally[1]. Achieving and maintaining a stable blood glucose concentration closest to the physiological standards is the main goal of DM therapy[2]. Insulin therapy is the only effective treatment for diabetes mellitus type 1; in addition, many people with DM 2 and other types one day reach a point at which insulin becomes the only way to achieve the goal of treatment. Continuous subcutaneous insulin infusion (CSII) is a method of insulin delivery into the patient's organism, and an alternative to multiple injections. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|